Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies. This drug was developed by Seattle Genetics, Inc.

PropertyValue
dbpedia-owl:abstract
  • Il dacetuzumab o SGN-40 o huS2C6) è un anticorpo monoclonale umanizzato; sviluppato nel trattamento dei linfomi non Hodgkin positivi all'antigene tumorale CD40. ed altri tumori ematologici. Viene sviluppato dalla Seattle Genetics, Inc.. Il target molecolare del farmaco è l'antigene: CD40.
  • Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies. This drug was developed by Seattle Genetics, Inc.
dbpedia-owl:atcPrefix
  • none
dbpedia-owl:casNumber
  • 880486-59-9
dbpprop:atcPrefix
  • none
dbpprop:c
  • 6452 (xsd:integer)
dbpprop:casNumber
  • 880486 (xsd:integer)
dbpprop:h
  • 9964 (xsd:integer)
dbpprop:mabType
  • mab
dbpprop:molecularWeight
  • 145 (xsd:integer)
dbpprop:n
  • 1732 (xsd:integer)
dbpprop:o
  • 1998 (xsd:integer)
dbpprop:s
  • 42 (xsd:integer)
dbpprop:source
  • zu/o
dbpprop:target
dbpprop:type
  • mab
dbpprop:unii
  • UT59FF4T5X
dbpprop:verifiedfields
  • changed
dbpprop:verifiedrevid
  • 400278911 (xsd:integer)
dbpprop:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • Il dacetuzumab o SGN-40 o huS2C6) è un anticorpo monoclonale umanizzato; sviluppato nel trattamento dei linfomi non Hodgkin positivi all'antigene tumorale CD40. ed altri tumori ematologici. Viene sviluppato dalla Seattle Genetics, Inc.. Il target molecolare del farmaco è l'antigene: CD40.
  • Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies. This drug was developed by Seattle Genetics, Inc.
rdfs:label
  • Dacetuzumab
  • Dacetuzumab
owl:sameAs
foaf:page
is owl:sameAs of
is foaf:primaryTopic of